These agents were equally effective in inhibiting STAT3 activity as 5- to tenfold higher concentrations of atovaquone, an anti-parasitic agent shown to induce STAT3 down-regulation in MM and AML cells [20]. This evidence concerns the gene STAT3 and Miyoshi myopathy.